Unlock instant, AI-driven research and patent intelligence for your innovation.

Anti-4-1BB nano antibody, coding gene and application

A nanobody, encoding gene technology, applied in the direction of antibodies, applications, genetic engineering, etc., to achieve the effect of wide application prospects

Active Publication Date: 2022-06-10
PEKING UNIV SHENZHEN GRADUATE SCHOOL
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Despite these responses, immunotherapy is often ineffective in eradicating mutated or infected cells
The causes of these failures can be grouped into three main types: (i) impaired recognition by immune cells, due to variable expression of antigens or reduced expression of major histocompatibility complex class I (MHC I) (6 ); (ii) immunosuppressive microenvironment, caused by immunosuppressive cells secreting inhibitory cytokines (eg, TGF-β, etc.); (iii) lack of expression of costimulatory molecules on mutant or infected cells The resulting tumors are poorly immunogenic (8), which leads to ineffective stimulation of T cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-4-1BB nano antibody, coding gene and application
  • Anti-4-1BB nano antibody, coding gene and application
  • Anti-4-1BB nano antibody, coding gene and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 14-1

[0066] Example 1 Expression and purification of 4-1BB protein

[0067] 1.1 Vector construction

[0068] The eukaryotic expression vector pFuse was used to construct the 4-1BB-Fc fusion protein, and 4-1BB and human IgG1 Fc were connected in series by PCR. The complete molecule included 4-1BB secretion signal peptide, 4-1BB extracellular domain, thrombin cleavage site, IEGRMD short peptide, human IgG1 hinge region, and CH2 and CH3 domains. The 4-1BB-Fc gene was double digested with NcoI and NheI and then cloned into the pFuse vector using T4 DNA ligase, or a homologous recombination kit was used to construct a vector.

[0069] 1.2 Eukaryotic expression

[0070] Inoculate 1.5×10 6 / mL 293F cells in 200mL culture medium in a 500mL shake flask. 37°C, 165rpm, 5% CO2 concentration in a shaking incubator for 24h, count the cells after 24h, and adjust the cell density to 3×10 6 / mL, add 200μg of the plasmid constructed in step 1.1 above to 10mL opti-MEM and mix gently, then let st...

Embodiment 2

[0077] Example 2 Construction and Screening of Anti-4-1BB Nanobody Phage Display Library

[0078] 2.1 Immunity of alpacas

[0079] Choose a healthy adult alpaca and mark the ear number. Mix 4-1BB protein with Freund's adjuvant at a ratio of 1:1 and store at 4°C. The left and right sides were injected near the lymph nodes in the alpaca neck, 2 points on each side, and 0.4 mL of mixed adjuvant antigen was injected each time. Observe for half an hour after immunization to confirm that the alpaca is in good condition and has no adverse reactions. Immunization was performed every 2 weeks, and a total of 7 immunizations were performed. At intervals of 5-7 days after the 6th and 7th immunization, the peripheral blood of the alpaca was collected from the neck vein for the construction of the phage display library.

[0080] 2.2 Isolation of lymphocytes derived from alpaca

[0081] Add 3 mL of cell separation medium to a 15 mL centrifuge tube, and slowly add 3 mL of blood sample. ...

Embodiment 3

[0151] Example 3 Sequencing

[0152] 3.1 Positive clone sequencing

[0153] Positive monoclonals were selected based on ELISA detection data and secondary verification data.

[0154] Take 5 μL of the positive clone liquid from the monoclonal ELISA detection plate and inoculate it into 2 mL of 2×YT medium (containing 100 μg / mL Amp and 10 μg / mL Tet), culture at 37°C, 250 rpm until OD 600 To 0.8-1.0 (about 6-8h), take 1mL of the bacterial liquid for sequencing, and store the rest of the bacterial liquid at 4°C.

[0155] 3.2 Sequence Analysis

[0156] The sequenced sequences were analyzed using GENtle software for sequence alignment, and the antibody sequences were translated into amino acids using GENtle software. The result is as Figures 7a-7e ,in Figure 7a shows the overall sequence similarity in the listed examples, Figure 7b~7e Sequence similarity between groups is shown.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
affinityaaaaaaaaaa
Login to View More

Abstract

The invention discloses an anti-4-1BB nano antibody, a coding gene and application of the anti-4-1BB nano antibody. The anti-4BB nano-antibody can be efficiently and specifically combined with 4-1BB, has the advantages of the nano-antibody and the costimulatory signal transduction capability of an immune system, can obtain a complete antibody sequence, can be stably produced in a high-quality manner through in-vitro recombinant expression, and has a wide application prospect.

Description

technical field [0001] The invention belongs to the technical field of biomedicine or biopharmaceuticals, and relates to an anti-4-1BB nanobody, coding gene and application. Background technique [0002] Multiple lines of evidence clearly demonstrate that some degree of immune response is often present in humans and animals. In patients with cancer and infectious diseases, cellular components of the immune system recognize mutated or antigens expressed by infected cells, such as differentiated or mutated gene products of carcinoembryonic antigen (1,2). Therapies utilizing immune modulatory mechanisms such as cytokines, bacterial products, cancer vaccines, and adaptive immunotherapy lead to tumor mutations in many patients (3-5). Despite these responses, immunotherapy is often ineffective in eradicating mutated or infected cells. The causes of these failures can be grouped into three main types: (i) impaired recognition by immune cells, due to variable expression of antigen...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/28C07K16/46C12N15/13A61K39/395A61P35/00A61P37/04A61P31/00
CPCC07K16/2878C07K16/005C07K16/2809A61P35/00A61P37/04A61P31/00C07K2317/22C07K2317/31C07K2317/569A61K2039/505Y02A50/30
Inventor 曹宇魏晓懿刘东齐学袖王雪纯李书宏赵丽丽刘忠
Owner PEKING UNIV SHENZHEN GRADUATE SCHOOL